Determinants of steady-state mycophenolate mofetil pharmacokinetics in lupus patients

被引:0
作者
Djabarouti, S.
Legeron, R. [1 ]
Saux, M. -C. [1 ]
Breilh, D. [1 ]
机构
[1] Pharm Hop Haut Leveque, Clin Pharmacokinet EA2968, Pessac, France
关键词
mycophenolic acid; pharmacokinetics; systemic lupus erythematosus;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:318 / 319
页数:2
相关论文
共 50 条
[21]   Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus [J].
Kawazoe, Mai ;
Kaneko, Kaichi ;
Yamada, Zento ;
Masuoka, Shotaro ;
Mizutani, Satoshi ;
Yamada, Soichi ;
Shikano, Kotaro ;
Sato, Hiroshi ;
Kaburaki, Makoto ;
Muraoka, Sei ;
Kawai, Shinichi ;
Nanki, Toshihiro .
CLINICAL RHEUMATOLOGY, 2019, 38 (06) :1571-1578
[22]   Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis [J].
Mizaki, Tomoko ;
Nobata, Hironobu ;
Banno, Shogo ;
Yamaguchi, Makoto ;
Kinashi, Hiroshi ;
Iwagaitsu, Shiho ;
Ishimoto, Takuji ;
Kuru, Yukiko ;
Ohnishi, Masafumi ;
Sako, Ken-ichi ;
Ito, Yasuhiko .
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2023, 9 (01)
[23]   Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis [J].
Tomoko Mizaki ;
Hironobu Nobata ;
Shogo Banno ;
Makoto Yamaguchi ;
Hiroshi Kinashi ;
Shiho Iwagaitsu ;
Takuji Ishimoto ;
Yukiko Kuru ;
Masafumi Ohnishi ;
Ken-ichi Sako ;
Yasuhiko Ito .
Journal of Pharmaceutical Health Care and Sciences, 9
[24]   Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus [J].
Djabarouti, Sarah ;
Duffau, Pierre ;
Lazaro, Estibaliz ;
Chapouly, Candice ;
Greib, Carine ;
Viallard, Jean-Francois ;
Pellegrin, Jean-Luc ;
Saux, Marie-Claude ;
Breilh, Dominique .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (05) :689-699
[25]   Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients [J].
Budde, K ;
Neumayer, HH ;
Lehne, G ;
Winkler, M ;
Hauser, IA ;
Lison, A ;
Fritsche, L ;
Soulillou, JP ;
Fauchald, P ;
Dantal, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (10) :2606-2614
[26]   Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients [J].
Foster, DJR ;
Somogyi, AA ;
Dyer, KR ;
White, JM ;
Bochner, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (05) :427-440
[27]   Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients [J].
Liu Li-feng ;
Wang Lu ;
Fu Qiang ;
Zhu Zhu ;
Xie Jing ;
Han Yang ;
Liu Zheng-yin ;
Ye Min ;
Li Tai-sheng .
CHINESE MEDICAL JOURNAL, 2012, 125 (11) :1931-1935
[28]   THEOPHYLLINE STEADY-STATE PHARMACOKINETICS IS NOT ALTERED BY OMEPRAZOLE [J].
TABURET, AM ;
GENEVE, J ;
BOCQUENTIN, M ;
SIMONEAU, G ;
CAULIN, C ;
SINGLAS, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (03) :343-345
[29]   Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin [J].
Ayalasomayajula, Surya P. ;
Vaidyanathan, Sujata ;
Kemp, Charisse ;
Prasad, Pratapa ;
Balch, Alfred ;
Dole, William P. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (05) :613-619
[30]   Effect of omeprazole on the steady-state pharmacokinetics of voriconazole [J].
Wood, N ;
Tan, K ;
Purkins, L ;
Layton, G ;
Hamlin, J ;
Kleinermans, D ;
Nichols, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 :56-61